<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01249495</url>
  </required_header>
  <id_info>
    <org_study_id>2010/736-2</org_study_id>
    <nct_id>NCT01249495</nct_id>
  </id_info>
  <brief_title>Treatment of Chronic Leg Ulcer in Outpatient's Department and i Primary Care - Wound Size and Inflammation</brief_title>
  <official_title>Treatment of Chronic Legg Ulcer in Outpatient's Department and i Primary Care - Wound Size and Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Aker</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the rate of wound healing using sharp debridement
      using curette and to compare between such intensive treatment at hospital and treatment in
      primary care. A correlation between change in wound size and pro-inflammatory cytokines will
      also be made.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with chronic venous leg ulcers are treated 3 times a week in the hospital for 6
      weeks with weekly sharp debridement. Wound size, pro-inflammatory cytokines, smears and photo
      are made weekly. The treatment countinue thereafter in primary care 3 times a week in 12
      weeks. Wound size, pro-inflammatory cytokines, smears and photo are made every 14 day at the
      hospital.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2010</start_date>
  <completion_date type="Anticipated">November 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment of chronic leg ulcer in outpatient's department at hospital and in primary care - wound size and inflammation.</measure>
    <time_frame>01.08.10-01.08.13</time_frame>
    <description>Wound size</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment of chronic leg ulcer in outpatient's department at hospital and in primary care - wound size and inflammation.</measure>
    <time_frame>01.08.10-01.08.13</time_frame>
    <description>Pro-inflammatory cytokines</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Treatment of Leg Ulcer</condition>
  <condition>Sharp Debridement</condition>
  <condition>Proinflammatory Cytokines</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sharp debridement</intervention_name>
    <description>After use of local anestetics a sharp currette is used to debride slough and nonviable tissue from the ulcer surface until a healthy tissue is seen.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ulcus cruris venosoum

          -  AAI &gt; 0.9

          -  age 18-80

          -  adress Oslo area

          -  wound size 2.5-100 cm2

          -  wound duration &gt; 6 weeks.

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Immunosuppresion

          -  antibiotics &lt; 14 days

          -  local antiseptic treatment &lt; 1 week

          -  clinical infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tone K Bergersen, MD;PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Oslo University Hospital;Dermatologic Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tone K Bergersen, MD;PhD</last_name>
    <phone>+47 22725829</phone>
    <email>kristin.bergersen@rikshospitalet.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brita Pukstad, MD</last_name>
    <phone>+47 95878012</phone>
    <email>brita.pukstad@ntnu.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oslo University Hospital, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tone Kristin Bergersen, MD, PhD</last_name>
      <phone>+ 47 95 277 814</phone>
      <email>kristin.bergersen@rikshospitalet.no</email>
    </contact>
    <investigator>
      <last_name>Tone K Bergersen, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2010</study_first_submitted>
  <study_first_submitted_qc>November 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2010</study_first_posted>
  <last_update_submitted>December 9, 2010</last_update_submitted>
  <last_update_submitted_qc>December 9, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2010</last_update_posted>
  <responsible_party>
    <name_title>Tone Kristin Bergersen</name_title>
    <organization>Oslo University hospital, Rikshospitalet, Dermatologic Department</organization>
  </responsible_party>
  <keyword>leg ulcer</keyword>
  <keyword>wound therapy</keyword>
  <keyword>Pro-inflammatory interleukins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

